US general surgeons report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed. Medscape
Author: Medscape
Medscape Neurologist Compensation Report 2026
US neurologists report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed. Medscape
Medscape Internist Compensation Report 2026
US internists report their 2025 compensation and satisfaction with it. Differences in doctor pay by gender, racial and ethnic group, and medical specialty are revealed. Medscape
On the Horizon: Dry Eye in Focus at ARVO 2026
A trio of studies from the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting show the potential of several emerging treatments for dry eye disease. Medscape Medical News
EyePoint’s Late-stage Eye Drug Trials to Continue After Safety Panel Review
EyePoint said on Thursday an independent safety committee found no new concerns in two late-stage trials of its experimental eye disease drug Duravyu and recommended the… Reuters Health Information
FDA Seeks Advice on Researching Drug Risks in Pregnancy
The FDA held a workshop on ways to improve collection of safety data on medicines used during pregnancy and released guidance for companies on postapproval pregnancy safety studies. Medscape Medical News
Gene-Agnostic Therapy Sees 3-year Gain in Severe Vision Loss
A treatment that targets dysfunctional photoreceptors regardless of the underlying genetic mutation leads to improved functional vision in advanced severe vision loss. Medscape Medical News
Gene-Agnostic Therapy Sees 3-Year Gain in Severe Vision Loss
A treatment that targets dysfunctional photoreceptors regardless of the underlying genetic mutation leads to improved functional vision in advanced severe vision loss. Medscape Medical News
The Pitt Season 2: EM Docs Tackle Tough Diagnoses (Part 3)
Drs Robert Glatter and Amy Faith Ho continue their review of The Pitt season 2, tackling retinal artery occlusion, phytophotodermatitis, and ovarian torsion. They unpack clinical accuracy, informed consent, and bias in emergency care. Medscape Emerg…
CGRP Inhibitors for Migraine Linked to Reduced Glaucoma Risk
The use of calcitonin gene-related peptide (CGRP) inhibitors to treat adults with migraine is linked to a 25% lower risk for glaucoma than the use of non-CGRP inhibitors, a new study shows. Medscape Medical News
Certain Multiple Sclerosis Drugs Tied to Lower Uveitis Risk
The use of nucleic acid synthesis inhibitors or sphingosine-1-phosphate modulators, fumarates, or interferons is linked to a lower risk for noninfectious uveitis in patients with MS, a new study finds. Medscape Medical News
Viridian Eye Disease Drug Surpasses Expectations in Late-stage Trial; Shares Soar
Viridian Therapeutics said on Tuesday its experimental thyroid eye disease drug met the main goal of a late-stage trial in chronic patients, sending its shares up nearly… Reuters Health Information
ARVO 2026
Read clinically focused news coverage of key developments from ARVO 2026. Medscape Ophthalmology
GLP-1 Drugs May Modestly Raise Optic Neuropathy Risk in T2D
GLP-1 therapy is linked to a modestly increased risk for nonarteritic anterior ischemic optic neuropathy compared with SGLT2 inhibitors in veterans with type 2 diabetes. Medscape Medical News
Vision Impairment: A Marker of Broader Health Risks
Visual impairment in adults signals broader health issues and is linked to a higher risk for death, particularly from noncardiovascular and noncancer causes, a recent cohort study shows. Medscape Medical News
How Oculomics Is Bringing Systemic Disease Into Focus
Oculomics, the study of eye biomarkers of systemic disease, is gaining traction as retinal imaging and AI advance. Tear testing could take the field in a new direction. Medscape Medical News
Brolucizumab Beats Laser Treatment in Diabetic Retinopathy
Intravitreal brolucizumab is superior to panretinal laser photocoagulation in preserving visual acuity for patients with proliferative diabetic retinopathy, clinical trial data show. Medscape Medical News
A Preliminary Look at Subtyping People With Type 2 Diabetes
Dr Anne Peters discusses the varying subtypes of diabetes. Medscape Diabetes & Endocrinology
Hydroxychloroquine Level Monitoring Can Boost Lupus Control
Weight-based dosing misses accounting for factors such as chronic kidney disease or chronic transaminitis, which could potentially accelerate toxicity risk or increase the risk for SLE flares. Medscape Medical News
Medscape Physician Wealth & Debt Report 2026
Physicians reveal how well their incomes help build family net worth, as well as investment and spending philosophies. Wealth disparities are reported by gender and race. Medscape